Prediction: This Is What $5,000 Invested in These 2 Nuclear Energy Stocks Will Be Worth in 10 Years

The cleaner expression of this theme is not “nuclear” broadly, but scarcity of firm, dispatchable power versus optionality on uranium. CEG has the better near-term monetization path because contracted megawatts and capacity-market pricing can re-rate cash flows within 1-3 quarters; CCJ needs uranium pricing and production discipline to convert policy optimism into equity returns, which is usually a slower, less linear process. In other words, the market is likely underpricing CEG’s earnings visibility and overpricing CCJ’s long-duration narrative premium.

The second-order winner set is the hyperscale customers locking in baseload supply, not because they get cheaper power, but because they de-risk future uptime and carbon constraints. META/MSFT can absorb higher power costs; the bigger pressure lands on smaller data-center developers and industrial users that compete for the same firm capacity, especially if PJM-style shortages persist. For CEG, the main risk is execution: integration debt plus any slippage on restart timing could compress the multiple even if power fundamentals stay tight.

Contrarian view: the bullish case for uranium may already be partly embedded in CCJ, while the market still treats nuclear as a single trade rather than two different balance-sheet and cash-flow profiles. A catalyst that reverses the move would be a softer forward power curve, weaker capacity auctions, or evidence that nuclear licensing reform stays procedural rather than accelerating actual megawatt additions. For CEG, watch adjusted EPS progression and leverage metrics; for CCJ, watch spot uranium and 2026-28 contract re-pricing—if either stalls, valuation compression can outrun earnings growth.